IDEAYA Biosciences IDYA
NASDAQ IDYA
$37.69 -0.12 (-0.32%)
As of: Oct 2, 2026 · 12:39 PM EDT

IDEAYA Biosciences (IDYA) Non-Current Deffered Revenue (2020 - 2025)

Updated

IDEAYA Biosciences (IDYA) posted Non-Current Deffered Revenue of $1.68 million for Q3 2025.

Analysis

IDEAYA Biosciences (IDYA) Non-Current Deffered Revenue (2020 - 2025) Analysis & Trends

At the end of FY2022, IDEAYA Biosciences' Non-Current Deffered Revenue came in at $5.19 million, down 83.4% from FY2021.

  • In prior years, IDEAYA Biosciences' Non-Current Deffered Revenue was $31.19 million in FY2021 (-44.5%) and $56.16 million in FY2020.
  • The Q3 2025 figure stands as the highest quarterly Non-Current Deffered Revenue in data going back to Q3 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 IDEAYA Biosciences 3.70 Bn 776.31 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 1.68 Mn
Dec 31, 2022 5.19 Mn
Sep 30, 2022 7.31 Mn
Jun 30, 2022 8.03 Mn
Mar 31, 2022 10.21 Mn
Dec 31, 2021 31.19 Mn
Sep 30, 2021 39.25 Mn
Jun 30, 2021 48.01 Mn
Mar 31, 2021 52.06 Mn
Dec 31, 2020 56.16 Mn
Sep 30, 2020 46.19 Mn
API Access

IDEAYA Biosciences Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=IDYA&period=max&api_key=YOUR_API_KEY